medigraphic.com
ISSN 0301-696X (Print)
Órgano de difusión del Servicio de Sanidad Militar y del Colegio Nacional de Médicos Militares

2018, Number 2

<< Back Next >>

Rev Sanid Milit Mex 2018; 72 (2)

Improved survival with multidisciplinary team intervention in the transcatheter aortic valve implant (TAVI) program

Martín HP, Gutiérrez LH, Ojeda DJL, Hernández JL, Honorato RMG, Silva RJA, Olivares GPI, Cambero SB

Language: Spanish
References: 18
Page: 98-104
PDF size: 263.78 Kb.


ABSTRACT

Introduction: The implantation of the transcatheter aortic valve (TAVI) is a minimally invasive and innovative treatment with good results for patients with aortic stenosis of intermediate or high surgical risk; However, the vast majority of patients are elderly and have multiple co-morbidities that lead to increased mortality and in many cases to complications. A crucial and determining point for a good evolution is the role of the heart team of an institution, since an incomplete team or with little experience leads to a poor selection of patients. In our institution, the heart team became a multidisciplinary team composed of several specialties for the comprehensive assessment of patients. Material and Methods: A cohort of 36 patients was carried out at the Central Military Hospital from September 2013 to October 2017. Thirty-six patients with aortic stenosis and treated with TAVI were met; The first 17 patients were evaluated by a cardiovascular surgeon, two interventional cardiologists, and two clinical cardiologists. Subsequently, a geriatrician, a pulmonologist, and a neurologist were included in the multidisciplinary team, among other specialties. Results: Of the 36 patients in total who were taken to TAVI, the first 17 patients selected by the heart team from the beginning of the program until 2015 (47.2%) and the last 19 patients (from 2015 to date) valued by the multidisciplinary team (52.7%). In the first group, they died during the follow-up at one year, 8 of 17 patients (47%) and in the second group, 2 patients of 19 (10.5%). Conclusions: The results of a program for TAVI are based on three strengths, the facilities, the training of the heart team and the experience of the valve implantation team, however, we form a multidisciplinary team composed of the heart team and another transcendental health personnel in the selection and follow-up of patients.


REFERENCES

  1. Freeman RV, Otto CM. Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies. Circulation. 2005; 111 (24): 3316-3326.

  2. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010; 363 (17): 1597-1607.

  3. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011; 364 (23): 2187-2198.

  4. Bypass Angioplasty Revascularization Investigation (BARI) Investigators. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med. 1996; 335 (4): 217-225.

  5. Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009; 360 (10): 961-972.

  6. Holmes DR Jr, Mack MJ, Kaul S, Agnihotri A, Alexander KP, Bailey SR et al. 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement. J Am Coll Cardiol. 2012; 59 (13): 1200-1254.

  7. Leon MB, Smith CR, Mack MJ, Makkar RR, Svensson LG, Kodali SK et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016; 374 (17): 1609-1620.

  8. Otto CM, Kumbhani DJ, Alexander KP, Calhoon JH, Desai MY, Kaul S et al. A Report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents: 2017 ACC Expert Consensus decision pathway for transcatheter aortic valve replacement in the management of adults with aortic stenosis: a report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol. 2017; 69 (10): 1313-1346.

  9. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Fleisher LA et al. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2017; 70 (2): 252-289.

  10. Antonides CF, Mack MJ, Kappetein AP. Approaches to the role of the heart team in therapeutic decision making for heart valve disease. Structural Heart. 2017; 1 (5-6): 249-255.

  11. Chalmers J, Pullan M, Fabri B, McShane J, Shaw M, Mediratta et al. Validation of EuroSCORE II in a modern cohort of patients undergoing cardiac surgery. Eur J Cardiothorac Surg. 2012; 43 (4): 688-694.

  12. Rankin JS, He X, O’Brien SM, Jacobs JP, Welke KF, Filardo et al. The Society of Thoracic Surgeons risk model for operative mortality after multiple valve surgery. Ann Thorac Surg. 2013; 95 (4): 1484-1490.

  13. Rosenhek R, Binder T, Porenta G, Lang I, Christ G, Schemper M et al. Predictors of outcome in severe, asymptomatic aortic stenosis. N Engl J Med. 2000; 343 (9): 611-617.

  14. Walther T, Hamm CW, Schuler G, Berkowitsch A, Kötting J, Mangner et al. Perioperative results and complications in 15,964 transcatheter aortic valve replacements: prospective data from the GARY registry. J Am Coll Cardiol. 2015; 65 (20): 2173-2180.

  15. Neily J, Mills PD, Young-Xu Y, Carney BT, West P, Berger DH et al. Association between implementation of a medical team training program and surgical mortality. JAMA. 2010; 304 (15): 1693-1700.

  16. Holmes DR Jr, Nishimura RA, Grover FL, Brindis RG, Carroll JD, Edwards FH et al. Annual outcomes with transcatheter valve therapy: from the STS/ACC TVT Registry. The Ann Thorac Surg. 2016; 101 (2): 789-800.

  17. Sintek M, Zajarias A. Patient evaluation and selection for transcatheter aortic valve replacement: the heart team approach. Prog Cardiovasc Dis. 2014; 56 (6): 572-582.

  18. Okoh AK, Chauhan D, Kang N, Haik N, Merlo A, Cohen M et al. The impact of frailty status on clinical and functional outcomes after transcatheter aortic valve replacement in nonagenarians with severe aortic stenosis. Catheter Cardiovasc Interv. 2017; 90 (6): 1000-1006.




2020     |     www.medigraphic.com